Why did The Pirbright Institute (Great Britain) PATENT the “CORONAVIRUS” ON Nov. 20, 2018?

Adara Press

Patent No.: US 10m 130, 701 B2
Date of Patent: Nov. 20, 2018


The present invention provides a live, attenuated coronavirus comprising a variant replicase gene encoding polyproteins comprising a mutation in or more of non-structural proteins(s) (nsp)-10, nsp-15, or nsp-16. The coronavirus may be used as a vaccine for treating and/or preventing a disease, such as infectious bronchitis, in a subject.

View original post

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.